Myocholine (Bethanechol Chloride)

Bethanechol, the active ingredient in Myocholine, is a muscarinic agonist presented as an oral formulation for use in adults. It stimulates smooth muscle contraction in the urinary tract and gastrointestinal system, helping to restore normal bladder emptying and intestinal motility after surgery or in neurogenic conditions. It is indicated for postoperative urinary retention, neurogenic bladder and postoperative ileus, and is administered under medical supervision.

GNH USA supplies Myocholine as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide, ensuring quality, regulatory compliance and reliable delivery across global markets.

Myocholine (bethanechol) acts on muscarinic receptors in the urinary and gastrointestinal tracts to promote smooth‑muscle contraction.

Postoperative urinary retention: enhances bladder contractility to facilitate voiding after surgery. Neurogenic bladder: improves detrusor muscle activity to aid bladder emptying in neurologic disorders. Postoperative ileus: stimulates intestinal smooth muscle to restore gastrointestinal motility after abdominal procedures.

Bethanechol may cause cholinergic‑related adverse reactions, varying from mild to serious.

Common Side Effects: - Abdominal cramps: mild to moderate discomfort in the abdomen. - Diarrhea: increased bowel movements. - Sweating: generalized hyperhidrosis. - Salivation: excess oral secretions. - Nausea: feeling of queasiness.

Serious or Rare Side Effects: - Bronchospasm: narrowing of airways that can impair breathing. - Severe hypotension: marked drop in blood pressure leading to dizziness or fainting. - Cardiac arrhythmia: irregular heart rhythm that may require medical attention.

Before prescribing Myocholine, clinicians should evaluate patient-specific factors and monitor for potential complications. - Assess renal function: adjust use in patients with significant impairment. - Monitor for cholinergic signs: watch for excessive salivation, sweating, or gastrointestinal upset. - Avoid in asthma or COPD: risk of bronchospasm may be heightened. - Use caution with cardiovascular disease: possible hypotension or arrhythmia. - Store at room temperature: keep in the original container, protect from moisture and direct sunlight.

Bethanechol can interact with other medications that influence cholinergic activity or cardiovascular function.

Major Interactions (Avoid): - Anticholinergic agents: may block the therapeutic effect of bethanechol. - Other muscarinic agonists: additive cholinergic stimulation can increase risk of severe side effects. - Cholinesterase inhibitors: may produce excessive cholinergic activity.

Moderate Interactions (Monitor Closely): - Beta‑blockers: may mask tachycardia caused by bethanechol. - Diuretics: can exacerbate hypotensive effects. - Anesthetic agents: may potentiate respiratory depression when combined.